Reprint

COVID-19: Current Status and Future Prospects

Edited by
March 2023
354 pages
  • ISBN978-3-0365-6740-2 (Hardback)
  • ISBN978-3-0365-6741-9 (PDF)

This book is a reprint of the Special Issue COVID-19: Current Status and Future Prospects that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Nearly 18 months later, COVID-19, caused by SARS-CoV-2, continues to present significant challenges to health systems, public health, and the economy of countries across both hemispheres. The morbidity and mortality of the infection caused by SARS-CoV-2 has been significant, and various waves of disease outbreaks initially overwhelmed hospitals and clinics in many countries and continue to do so. This influences everyone, and public health countermeasures have been dramatic in terms of their impact on employment, social systems, and mental health.

This Special Issue collection follows on from the Special Issue “COVID-19: Current Challenges and Future Perspectives” and provides an avenue for authors from various disciplines to provide feedback on the response to and our future global preparedness for COVID-19, as well as to disseminate critical information about SARS-CoV-2 and the associated COVID-19 pandemic.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
COVID-19; new-onset DM; severe infection; mortality; outbreak; P.1 variant; Gamma variant; SARS-CoV-2 infection; COVID-19; whole-genome sequencing; COVID-19; pandemic; overweight; obesity; Peru; COVID-19; psychological impacts; public health; preparedness; mRNA-1273; BNT162b2; TAK-919; COVID-19; SARS-CoV-2; post-vaccination; healthcare personnel; pandemic; vaccination; asymptomatic infection; COVID-19; HIV; public health; pandemic; infectious disease; excess mortality; COVID-19; mortality; Peru; regdanvimab; remdesivir; COVID-19; severe; COVID-19; SARS-CoV-2; community transmission; population density gradient; Dhaka; Bangladesh; dengue; COVID-19; SARS-CoV-2; undifferentiated febrile illness; antigen testing; COVID-19; SARS-CoV-2; variants; reinfections; breakthrough infections; vaccination; COVID-19; vaccine hesitancy; sub-Saharan Africa; pulmonary fibrosis; postacute COVID-19 syndrome; tuberculosis; helminth coinfection; sub-Saharan Africa; coronavirus; coordination; health operations and technical expertise; AFRO; COVID-19; SARS-CoV-2; diarrhea; liver; pancreas; inflammatory bowel diseases; liver transplantation; reproduction rate; phylogenetic analysis; clade GK; D614G; P681R; COVID-19; cross-reactivity; dengue; haemorrhage; thrombocytopenia; thrombosis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV2); COVID-19; molecular diagnostics; real-time polymerase chain reaction (RT-qPCR); COVID-19; economy; income levels; mortality; waves; policy; turning points; COVID-19; SARS-CoV-2; occupational exposure; risk factors; personal protective equipment; SIR model; socio-behavioral aspects; interaction distance; school reopening strategy; self-medication; COVID-19; pandemic; over-the-counter; medicine use; Pakistan; SARS-CoV-2; COVID-19; clinical features; Luanda; Angola; socioeconomic status; risk perception; risk prevention practices; qualitative; COVID-19; n/a